<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Rare Disease Clinical Trials Go Uncompleted and Unpublished
Image Overlay - Rare Disease Clinical Trials Go Uncompleted and Unpublished

Rare Disease Clinical Trials Go Uncompleted and Unpublished

December 10, 2019

Rare Disease Clinical Trials Go Uncompleted and Unpublished

A new study published in PLOS Medicine investigating 659 clinical trials for rare diseases found that over half of the trials either were discontinued or the results went unpublished four years after completion. For both the incomplete and the unpublished studies, the primary reason was difficulties enrolling sufficient numbers of patients. Yourway is constantly exploring ways to facilitate trials for rare diseases, including direct-to-patient trials services and other new trials models.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat
Come chat with us!
Hello! How can I help you?